Table 1.
- Demographic, clinical, and tumor characteristics of patients with ovarian cancer (N=144).
| Variable | Median (range) | n | (%) |
|---|---|---|---|
| Age (years) | |||
| 20-39 | 41 | (28.5) | |
| 40-59 | 66 | (45.8) | |
| 60-85 | 37 | (25.7) | |
| Median (range) | 49.5 (20.0-85.0) | ||
| Marital status | |||
| Never married | 22 | (15.3) | |
| Married | 122 | (84.7) | |
| Body mass index (kg/m2) | |||
| Underweight (<18.5) | 5 | (3.5) | |
| Normal (18.5-24.9) | 38 | (26.4) | |
| Overweight (25.0-29.9) | 49 | (34.0) | |
| Obese (30+) | 52 | (36.1) | |
| Median (range) | 27.9 (14.6-44.73) | ||
| Parity | |||
| Nullipara | 38 | (26.4) | |
| 1-3 | 55 | (38.2) | |
| >4 | 51 | (35.4) | |
| Median (range) | 3 (0-13) | ||
| Medical disease | |||
| No | 69 | (47.9) | |
| Yes | 75 | (52.1) | |
| Histopathology | |||
| Serous | 110 | (76.4) | |
| Non-serous | 34 | (23.6) | |
| Mucinous | 24 | (16.7) | |
| Endometroid | 8 | (5.6) | |
| Clear cell | 2 | (1.4) | |
| Stage | |||
| I | 42 | (29.2) | |
| II | 16 | (11.1) | |
| III | 69 | (47.9) | |
| IV | 17 | (11.8) | |
| Grade | |||
| 1 | 37 | (25.7) | |
| 2 | 26 | (18.1) | |
| 3 | 81 | (56.3) | |
| Residual disease | |||
| 0 | 77 | (53.5) | |
| <1 | 16 | (11.1) | |
| >1 | 51 | (35.4) | |
| Chemotherapy | |||
| No | 44 | (30.6) | |
| Yes | 100 | (69.4) | |
| Carboplatin and paclitaxel | 82 | (56.9) | |
| Carboplatin alone | 18 | (18.0) | |
| Disease progression | |||
| No | 90 | (62.5) | |
| Recurrence | 49 | (34.0) | |
| Persistent disease | 5 | (3.5) | |
| Last follow up status | |||
| Alive | 76 | (52.8) | |
| Deceased | 68 | (47.2) | |
| Follow up period (years) | |||
| Median (range) | 3.4 (2.2-17.1) | ||
| Mean (SD) | 4.43 (3.90) | ||